NSPR

InspireMD, Inc.

1.61

USD

NSPR Earnings Reports

Positive Surprise Ratio

NSPR beat 24 of 30 last estimates.

80%

Next Report

Date of Next Report

Mar 10, 2026

Estimate for Q4 25 (Revenue/ EPS)

$2.67M

-$0.20

Implied change from Q3 25 (Revenue/ EPS)

+5.92%

+17.65%

Implied change from Q4 24 (Revenue/ EPS)

+37.12%

+5.26%

InspireMD, Inc. earnings per share and revenue

On Nov 04, 2025, NSPR reported earnings of -0.17 USD per share (EPS) for Q3 25, beating the estimate of -0.19 USD, resulting in a 14.53% surprise. Revenue reached 2.52 million, compared to an expected 1.80 million, with a 40.54% difference. The market reacted with a -7.21% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 2.67 million USD, implying an increase of 17.65% EPS, and increase of 5.92% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

AngioDynamics, Inc.

Report Date

Jan 06, 2026 For Q2 26

Estimate

-$0.10

Actual

$0.00

Surprise

+100.00%

FAQ

What were InspireMD, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, InspireMD, Inc. reported EPS of -$0.17, beating estimates by 14.53%, and revenue of $2.52M, 40.54% above expectations.

How did the market react to InspireMD, Inc.'s Q3 2025 earnings?

The stock price moved down -7.21%, changed from $2.29 before the earnings release to $2.13 the day after.

When is InspireMD, Inc. expected to report next?

The next earning report is scheduled for Mar 10, 2026.

What are the forecasts for InspireMD, Inc.'s next earnings report?

Based on 4 analysts, InspireMD, Inc. is expected to report EPS of -$0.20 and revenue of $2.67M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.